A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.
Clinical trial NCT00295763 · COMPLETED
Trial details
- NCT number
- NCT00295763
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2006-07-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.